Effectiveness of Ankle Foot Orhoses on Spinal Posture and Balance in Cerebral Palsy

June 23, 2024 updated by: Seda AYAZ TAŞ, Abant Izzet Baysal University

How the Use of Ankle Foot Orhoses Affects Spinal Posture and Balance in Children With Cerebral Palsy

Background: Evidence on the effect of Ankle Foot Orthoses (AFO) on spinal posture which is very important for postural control, is insufficient.The aim of the study was to investigate the effect of AFO in spinal posture, balance and lower extremity functional skills in children with Cerebral Palsy (CP).

Methods: This study was conducted using a repeated-measures design. 25 children with CP aged 6-17 years were included. Children were classified according to the Gross Motor Function Classification System (GMFCS), Manual Skills Classification System (MACS) and Communication Function Classification System (CFCS). Spinal postures with Spinal Mouse (SM), balance and lower extremity functional skills were evaluated using the Pediatric Berg Balance Scale, Pediatric Functional Reach and Timed Up & Go Test twice with AFO and barefoot.

Study Overview

Detailed Description

Cerebral palsy (CP) is defined as an umbrella term used as a group of permanent disorders of movement and posture development due to damage to the infant or fetus brain . CP shows a wide range of motor impairments including spasticity, muscle weakness, postural control deficits, and balance and gait disorders. These multifaceted motor limitations significantly affect the functional capacity of children with CP, limiting their participation in daily activities and significantly reducing their overall quality of life.

Poor motor control, abnormal biomechanical alignment, poor muscle activation, impaired agonist-antagonist muscle balance and balance disorders are the most common motor disorders in CP. Therefore, orthoses are prescribed in addition to rehabilitation for prevention and correction of deformities, improvement of postural control parameters, maintenance of correct muscle lengths.

The aim of this study was to investigate the effect of AFO use on spinal posture, balance and lower extremity functional skills in CP.

In this study, 25 Syrian children under temporary protection with spastic type CP were included. After obtaining permission from Abant Izzet Baysal University Clinical Research Ethics Committee (2022/339), informed consent was obtained from the children under temporary protection and their parents who volunteered to participate in the study. Inclusion criteria were as follows: 1) being diagnosed with spastic type CP between the ages of 6-18, 2) GMFCS level I, II or III, 3) using AFO for at least 3 months. All children were familiar with their AFO's. Exclusion criteria:1) presence of rigid contracture in the trunk and lower extremities. Demographic characteristics of the children (age, body weight, height, gender) were recorded.

Functionalities of the children were classified according to the Gross Motor Function Classification System (GMFCS), Manual Ability Classification System (MACS) and Communication Function Classification System (CFCS). Spinal postures were evaluated with Spinal Mouse (SM), balance and lower extremity functional skills were evaluated with Paediatric Berg Balance Scale, Pediatric Functional Reach Test and Timed Up & Go Test. All these evaluations were repeated twice in children with AFO and barefoot. The evaluations were completed on two non-consecutive days. The results of both assessments were recorded and analysed.

Study Type

Observational

Enrollment (Actual)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bolu, Turkey, 14030
        • Bolu Abant İzzet Baysal Üniversity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

In this study, 25 Syrian children under temporary protection with spastic type CP were included.

Description

Inclusion Criteria:

  1. being diagnosed with spastic type CP between the ages of 6-18,
  2. GMFCS level I, II or III,
  3. using AFO for at least 3 months.

Exclusion Criteria:

1) presence of rigid contracture in the trunk and lower extremities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal posture
Time Frame: Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 30 min
Spinal posture and mobility were evaluated with the Spinal Mouse in the standing position, placing weight on both lower extremities, as symmetrically as possible. By following the spinous processes paravertebrally on the skin surface, the device was moved from C7 to the anima rami (S3) and the information about the thorax, lumbar and sacrum/hip angles transferred to the computer via bluetooth was recorded. Measurements in the sagittal plane, standing upright, maximum trunk flexion and maximum trunk extension position; The measurements in the frontal plane were performed in 3 different positions as standing, right trunk lateral flexion and left trunk lateral flexion.
Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 30 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Balance
Time Frame: Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 15 min
Pediatric Berg Balance Scale (PBBS): The scale consists of 14 sections and each section is scored between 0-4; the highest score that can be obtained from the scale is 56.
Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 15 min
Dynamic balance
Time Frame: Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 5 min
Pediatric Functional Reach Test: It is a dynamic balance test in which the maximum distance that can be reached to the front and sides during standing upright posture is measured. The tape measure was placed on the wall at shoulder height in order to measure the distance reached
Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 5 min
Functional mobility
Time Frame: Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 5 min
Time up & Go Test (TUG): The activities that make up the test assess the transition from sitting to standing, walking, turning and sitting again, which are necessary for functional mobility and dynamic balance. The time required for the child to get up from a standard chair with armrests, walk a distance of 3 metres, turn from a designated or marked place, return to the chair and sit down again was measured in seconds
Measurements were made between the dates 07.01.2024-10.02.2024.The measurement of each individual took approximately 5 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2020

Primary Completion (Actual)

January 7, 2024

Study Completion (Actual)

February 10, 2024

Study Registration Dates

First Submitted

June 7, 2024

First Submitted That Met QC Criteria

June 23, 2024

First Posted (Actual)

June 25, 2024

Study Record Updates

Last Update Posted (Actual)

June 25, 2024

Last Update Submitted That Met QC Criteria

June 23, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Subscribe